Allan Will

Allan Will has extensive experience in various leadership roles in the medical technology industry. Since 2014, they have been the Director at the Fogarty Institute for Innovation. Prior to that, they served as the Chair of the Board of Directors at Fractyl starting from 2012. In 2011, they held the position of Executive Chair of the Board of Directors at EBR Systems, Inc., as well as Chair of the Board of Directors at SetPoint Medical. From 2010 to 2011, they were the Chair of the Board of Directors at Ardian, Inc. Allan also has experience in venture capital, as the Managing Director and Founder of Split Rock Partners from 2002 to 2010. Furthermore, they founded and held leadership positions at The Foundry, LLC from 1998 to 2010. Prior to that, they served as Chief Executive Officer and Director at AneuRx (Medtronic) from 1994 to 1998, as well as Chief Executive Officer and Director at Redwood Interventional in 1994. Allan began their career in 1986 as the Chief Executive Officer and Director at Devices for Vascular Intervention (Eli Lilly & Co.).

Allan Will's education history begins in 1972 when they attended Washington and Lee University. However, no degree or field of study information is available for this period.

In 1973, Allan enrolled in the University of Maryland and pursued a Bachelor of Science (B.S.) degree in Zoology/Biology. Allan'sstudies continued at the University of Maryland until 1976, when they completed their undergraduate education.

After a break in their education, Allan returned to academia in 1980 and attended the Massachusetts Institute of Technology (MIT). During their time at MIT, which lasted until 1981, Allan pursued a Master of Science (MS) degree in Management.

Based on the provided information, Allan Will's educational journey includes a Bachelor's degree in Zoology/Biology from the University of Maryland and a Master's degree in Management from the Massachusetts Institute of Technology.